|
Minimal inhibitory concentration (ug/ml)
|
|---|
|
Antibiotics
|
K. pneumoniaeST11 (n = 25)
|
NDM-1positiveK.pneumoniae (n = 7)
|
|---|
| |
range
|
range
|
|---|
|
AMP
|
≥512
|
≥512
|
|
CAZ
|
≥512
|
≥512
|
|
CTX
|
128- > 512
|
64- > 512
|
|
FOX
|
64–256
|
64–256
|
|
FEP
|
64–256
|
16–64
|
|
CXM
|
≥512
|
≥512
|
|
ATM
|
≥512
|
1–2
|
|
GN
|
64–256
|
0.25–0.5
|
|
LEV
|
32–128
|
0.06–0.25
|
|
AK
|
≥512
|
1–2
|
|
CIP
|
≥32
|
0.06–1
|
|
TZP
|
64/4- > 256/4
|
128/4- > 256/4
|
|
SXT
|
1/19–2/38
|
≥256/4864
|
|
IPM
|
8–64
|
1–16
|
|
MEM
|
4–32
|
1–32
|
|
TGC
|
0.06–0.5
|
0.06–0.5
|
|
CO
|
0.03–0.5
|
0.06–0.25
|
- AMP ampicillin (0.06–512), CAZ ceftazidime (0.06–512), CTX cefotaxime (0.06–512), FEP cefepime (0.06–512), CXM cefuroxime (0.06–512), FOX cefoxitin (0.06–512), GN gentamicin (0.06–512), LEV levofloxacin (0.06–512), AK amikacin (0.06–512), CIP ciprofloxacin (0.004-32), ATM Aztreonam (0.06–512), IPM imipenem (0.03–256), MEM meropenem (0.03–256), TZP piperacillin-tazobactam (0.25/4–256/4), SXT trimethoprim-sulfamethoxazole (0.25/4.75–256/4864), TGC tigecycline (0.03–256), CO colistin (0.03–256)
